NCT02376218View on ClinicalTrials.gov

Post-lobectomy Use of Glucose for Pleurodesis and Air-leak Cessation. A Feasibility Trial.

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Pulmonary Surgical Procedures
Interventions
DRUG

Hypertonic 50% dextrose pleurodesis

Intrapleural administration of 180ml of hypertonic dextrose solution.

Trial Locations (1)

N6A 5W9

London Health Sciences Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT02376218 - Post-lobectomy Use of Glucose for Pleurodesis and Air-leak Cessation. A Feasibility Trial. | Biotech Hunter | Biotech Hunter